SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.15-0.7%Jan 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dlc who wrote (9324)3/23/1999 2:13:00 AM
From: aknahow  Read Replies (1) of 17367
 
dlc, while you posted, "I am disturbed by all the hype surrounding the end
of the trial when the real announcement is still a long way off.", it is possible that far from being hype the extension of the trial generated two camps. One felt the extension meant bad news and the other that it was more probably good news as the longer it takes to complete the trial, the more likely the drug is having some positive effect. What we have been unable to pin down is, has the standard of care in the U.K. changed so much for the better, that the mortality rate for the placebo group has declined significantly.

At any rate good to see you post again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext